DGS Capital Management’s GSK GSK Stock Holding History

DGS Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.36M	Buy	42,695 +2,761	+7%	+$150K	0.39%	42
2025 Q4	$1.96M	Buy	39,934 +3,592	+10%	+$168K	0.33%	52
2025 Q3	$1.57M	Buy	36,342 +3,778	+12%	+$148K	0.29%	61
2025 Q2	$1.25M	Buy	32,564 +3,430	+12%	+$131K	0.26%	69
2025 Q1	$1.13M	Buy	29,134 +866	+3%	+$31.7K	0.3%	63
2024 Q4	$956K	Sell	28,268 -6,170	-18%	-$222K	0.24%	76
2024 Q3	$1.41M	Buy	34,438 +1,304	+4%	+$53.3K	0.38%	46
2024 Q2	$1.28M	Buy	33,134 +2,443	+8%	+$103K	0.36%	45
2024 Q1	$1.32M	Buy	30,691 +466	+2%	+$19.2K	0.37%	38
2023 Q4	$1.12M	Sell	30,225 -7,238	-19%	-$260K	0.43%	38
2023 Q3	$1.36M	Buy	37,463 +4,403	+13%	+$156K	0.66%	25
2023 Q2	$1.18M	Buy	33,060 +5,220	+19%	+$187K	0.59%	30
2023 Q1	$991K	Buy	27,840 +4,893	+21%	+$171K	0.55%	32
2022 Q4	$806K	Buy	22,947 +9,503	+71%	+$317K	0.53%	42
2022 Q3	$396K	Buy	13,444 +8,479	+171%	+$321K	0.26%	83
2022 Q2	$270K	Buy	+4,965	New	+$274K	0.22%	122

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DGS Capital Management's GSK Position: Q1 2026 in Review

DGS Capital Management increased its GSK (GSK) stake by 6.9% in Q1 2026, buying an estimated $150K and bringing the position to 42,695 shares worth $2.36M. The position accounts for 0.39% of the portfolio, ranked #42.

DGS Capital Management first reported a position in GSK in Q2 2022 and has held it in 16 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

DGS Capital Management held 42,695 shares of GSK worth $2.36M as of Q1 2026.
DGS Capital Management bought 2,761 GSK shares in Q1 2026, an estimated $150K.
GSK made up 0.39% of DGS Capital Management's portfolio in Q1 2026, its #42 holding.
DGS Capital Management first reported a position in GSK in Q2 2022 and has held it in 16 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.